Both medications contain the active ingredient which also mimic the naturally occurring gastrointestinal hormone GLP-1 but also mimics the GI hormone gastric inhibitory peptide (GIP)
Contact your GP or optometrist promptly if you experience: Sudden vision changes , including blurred vision, floaters (dark spots or strings), or flashes of light Progressive difficulty reading or recognising faces Dark or empty areas in your visual field Distorted vision , where straight lines appear wavy Eye pain or redness accompanied by vision changes Difficulty with night vision or colour perception If you experience sudden, painless vision loss in one or both eyes, this constitutes an ophthalmological emergency
In our GaMD simulations, this BACH1 facing loop of FBXO22 only forms a -sheet structure when BACH1 is present (Supplementary Figs
It remains an investigational compound, developed by Eli Lilly and Company, and is currently undergoing Phase 3 clinical trials
However, over time, the body adjusts to these changes, and the weight can start to creep back up